Fortitude Family Office’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.3K Buy
82
+24
+41% +$7.44K ﹤0.01% 740
2026
Q2
$16.2K Sell
58
-5
-8% -$1.31K ﹤0.01% 598
2026
Q1
$16.8K Sell
63
-72
-53% -$19.5K ﹤0.01% 476
2025
Q4
$33.9K Hold
135
– – 0.01% 300
2025
Q3
$38.8K Hold
135
– – 0.01% 276
2025
Q2
$35.4K Buy
135
+3
+2% +$731 0.01% 292
2025
Q1
$30.7K Hold
132
– – 0.01% 310
2024
Q4
$30.3K Buy
132
+100
+313% +$22.9K 0.01% 363
2024
Q3
$7.15K Hold
32
– – ﹤0.01% 657
2024
Q2
$6.51K Sell
32
-6
-16% -$1.22K ﹤0.01% 507
2024
Q1
$8.3K Hold
38
– – 0.01% 440
2023
Q4
$8.64K Buy
+38
New +$7.98K 0.01% 450

Other funds holding LH

Fortitude Family Office's LH Position: Q3 2026 in Review

Fortitude Family Office increased its Labcorp (LH) stake by 41% in Q3 2026, buying an estimated $7.44K and bringing the position to 82 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Fortitude Family Office first reported a position in LH in Q4 2023 and has held it in 12 quarters since. The position peaked at $38.8K in Q3 2025. 88 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Fortitude Family Office held 82 shares of Labcorp worth $25.3K as of Q3 2026.
  • Fortitude Family Office bought 24 Labcorp shares in Q3 2026, an estimated $7.44K.
  • Labcorp made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #740 holding.
  • Fortitude Family Office first reported a position in Labcorp in Q4 2023 and has held it in 12 quarters since.
  • Fortitude Family Office's Labcorp position peaked at $38.8K in Q3 2025.
  • 88 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.